VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $423.00K in the twelve months ending March 31, 2024, with 6.28% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $98.00K, a -1.01% decrease year-over-year. In the year 2023, VYNE Therapeutics had annual revenue of $424.00K, a decrease of -11.11%.

• Revenue (ttm): $423.00K
• Revenue Growth: +6.28%
• P/S Ratio: 87.24
• Revenue / Employee: $42,300
• Employees: 10
• Market Cap: 36.90M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%
Dec 31, 2019	443.00K	-3.15M	-87.68%
Dec 31, 2018	3.60M	-987.00K	-21.54%
Dec 31, 2017	4.58M	3.91M	579.82%
Dec 31, 2016	674.00K	-	-
Dec 31, 2015	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.